Curcumin and doxorubicin encapsulated in biocompatible clay‐based nanomaterial: A strategy to overcome multidrug resistance
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.202400702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Paola Poma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Palermo, Italy. Hauptthemen laut MEDLINE: Curcumin, Doxorubicin, Drug Resistance, Neoplasm, Drug Resistance, Multiple. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PJ_UTILE_2022_VQR_Misura_B_D15_Notarbartolo of University of Palermo and PRIN PNNR - P2022YJZ5F.
Abstract (Originalsprache)
Multidrug resistance (MDR) due to the overexpression of the P‐glycoprotein (P‐gp) efflux pump remains a significant challenge in cancer therapy, also in breast cancer. Traditional pharmacological approaches have focused on using inhibitors to modulate P‐gp expression and function. Curcumin, a polyphenol derived from Curcuma longa L., is one of the most extensively studied natural compounds with the potential as an effective P‐gp inhibitor. Despite its promising attributes, the clinical application of P‐gp inhibitors is complicated by P‐gp's presence in healthy cells, such as those in the intestinal barrier and blood–brain barrier, which can lead to increased toxicity. To address these challenges, we developed a novel multifunctional nanomaterial by covalently bonding halloysite nanotubes (HNTs) with hectorite (Ht) and loading it with curcumin and doxorubicin. The efficacy of the co‐delivery of curcumin and doxorubicin by HNTs‐Ht nanomaterial was evaluated by cytotoxicity assays on MCF‐7R cells, both in two‐dimensional (2D) and in three‐dimensional (3D) models. The obtained data show that curcumin causes increased doxorubicin accumulation by acting as a substrate for P‐gp transport and as a stimulator of the adenosine triphosphate (ATP)‐dependent drug efflux transporter on a doxorubicin‐resistant breast cancer cell line. The results suggest that the HNTs‐Ht nanomaterial could provide a promising approach to improve chemotherapy effectiveness by overcoming MDR and enhancing treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Palermo, Italy.
- Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Granada, Spain.
- Andalusian Institute of Earth Sciences, CSIC-UGR, Armilla, Granada, Spain.
- Dipartimento di Scienze Chimiche (DSC), Università di Catania, Catania, Italy.
Förderung
- PJ_UTILE_2022_VQR_Misura_B_D15_Notarbartolo of University of Palermo and PRIN PNNR - P2022YJZ5F
Zitieren
APA
Poma, P., Massaro, M., Rigogliuso, S., Condorelli, L., Sánchez-Espejo, R., Viseras, C., Notarbartolo, M., & Riela, S. (2025). Curcumin and doxorubicin encapsulated in biocompatible clay‐based nanomaterial: A strategy to overcome multidrug resistance. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400702
Vancouver
Poma P, Massaro M, Rigogliuso S, Condorelli L, Sánchez-Espejo R, Viseras C, et al. Curcumin and doxorubicin encapsulated in biocompatible clay‐based nanomaterial: A strategy to overcome multidrug resistance. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400702
BibTeX
@article{Poma2025,
author = {Poma, Paola and Massaro, Marina and Rigogliuso, Salvatrice and Condorelli, Lucia and Sánchez-Espejo, Rita and Viseras, César and Notarbartolo, Monica and Riela, Serena},
title = {Curcumin and doxorubicin encapsulated in biocompatible clay‐based nanomaterial: A strategy to overcome multidrug resistance},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.202400702}
}
EUVIMED